Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia...

[HTML] sciencedirect.com

[HTML][HTML] Real-world experience with CPX-351 in high-risk acute myeloid leukemia

RM Lemoli, P Montesinos, A Jain - Critical reviews in oncology/hematology, 2023 - Elsevier
Abstract CPX-351, a dual-drug liposomal encapsulation of daunorubicin/cytarabine, was
approved for newly diagnosed therapy-related acute myeloid leukemia (AML) and AML with …
被引用次数：3 相关文章 所有 4 个版本